Max Robotics — Global Service Robot Directory + US Certification

About

Fengjiao Li is a pioneering researcher whose work bridges advanced materials science and oncological surgery, demonstrating remarkable interdisciplinary impact. Her primary research areas include liquid metal printing technologies and HPV-positive oropharyngeal cancer treatment. In materials science, Li’s seminal 2023 review on liquid metal printing has garnered 14 citations, systematically cataloging breakthroughs in catalytic deposition, 2D lamellar growth, free radical polymerization, and photo/electrocatalysis. She has advanced liquid metal composites with enhanced magnetic, thermal, electrical, and tensile properties, opening new frontiers in flexible electronics and sustainable manufacturing. Simultaneously, Li has made transformative contributions to oncology. Her 2025 phase 2 trial (4 citations) introduced neoadjuvant sintilimab with chemotherapy followed by transoral robotic surgery (TORS) for HPV-positive oropharyngeal cancer, achieving major pathological responses in resectable cases. Her 2024 study (3 citations) further elucidated how HPV infection influences prognosis in TORS-treated patients, refining treatment paradigms for this rising malignancy. Li’s dual expertise exemplifies how cross-disciplinary innovation can drive progress from lab-scale material synthesis to clinical translation, making her work essential reading for researchers in both nanotechnology and head-and-neck oncology.